drugset / Trial / NCT02359292
Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The study is performed to evaluate the total systemic exposure and lung bioavailability of CHF 5993 pMDI combination, in healthy volunteers subjects.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-04
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CHF 5993 | Other / unclassified | — | Inhaled |
| Subject | Charcoal Block | Unknown | — | — |